Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia GravisNCT06193889Kyverna TherapeuticsPhase 2, Phase 3Recruiting2027-09Estimated
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension StudyNCT06194799ACADPhase 3Enrolling by invitation2029-04Estimated
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)NCT06196879UPBPhase 2Completed2025-12-16Actual
A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)NCT06203002Lexicon PharmaceuticalsPhase 2Completed2025-01-14Actual
Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ AdenocarcinomaNCT06206278LianBio LLCPhase 2Terminated2024-05-31Actual
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for BabesiosisNCT0620737060 Degrees Pharmaceuticals LLCPhase 2Recruiting2027-03-01Estimated
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGNNCT06209736Omeros CorporationPhase 2Terminated2026-04-14Actual
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCNCT06216301NovoCure GmbHPhase 3Recruiting2028-10Estimated
A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on DialysisNCT06218290UNCYPhase 2Completed2024-05-29Actual
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenerationNCT06223958OCULPhase 3Active not recruiting2026-04-29Estimated
Evaluating LP-10 in Subjects With OLPNCT06233591Lipella Pharmaceuticals, Inc.Phase 2Unknown2025-06-01Estimated
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway ImpairmentNCT06239116RYTMPhase 1, Phase 2Active not recruiting2027-05-07Estimated
SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic MalformationsNCT06239480PVLAPhase 3Active not recruiting2026-01-14Actual
A Study of ANAVEX3-71 in Adults With SchizophreniaNCT06245213AVXLPhase 2Active not recruiting2025-06-30Estimated
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLCNCT06246110Eikon TherapeuticsPhase 2Active not recruiting2026-12Estimated
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care TreatmentNCT06247085TVTXPhase 3Recruiting2027-08Estimated
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)NCT06263231INTSPhase 3Recruiting2027-12Estimated
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]NCT06264180Replimune, Inc.Phase 3Recruiting2030-09-30Estimated
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)NCT06270836KODPhase 3Completed2026-02-13Actual
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801Gossamer Bio USA, Inc.Phase 3Recruiting2026-12Estimated
Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in AdultsNCT06279871Arcturus Therapeutics, Inc.Phase 3Completed2024-10-09Actual
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight MgmtNCT06282458VERUPhase 2Completed2025-04-11Actual
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerNCT06282575Jazz PharmaceuticalsPhase 3Recruiting2028-12-01Estimated
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination VaccineNCT06291857NovavaxPhase 3Completed2025-12-24Actual
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsNCT06292923TLSAPhase 2Completed2026-09-17Actual
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)NCT06295731INBXPhase 2, Phase 3Recruiting2029-12Estimated
A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyeNCT06296966Vanda PharmaceuticalsPhase 2Unknown2024-07Estimated
Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal HemoglobinuriaNCT06298955Omeros CorporationPhase 2Active not recruiting2026-12Estimated
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)NCT06302348PTC TherapeuticsPhase 3Recruiting2031-02-28Estimated
A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.NCT06319456Ascentage Pharma Group Inc.Phase 3Recruiting2027-08Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.